Press Releases | Association for Accessible Medicines

FDA's Competitive Generic Therapy (CGT) Designation

Aug 8, 2018 | Rachel Schwartz

AAM Statement in Response to FDA's Competitive Generic Therapy (CGT) Designation

Jul 19, 2018 | Allen Goldberg

AAM Statement on Importation Task Force

AAM Statement on FDA’s Biosimilars Action - Press Release Header

Jul 18, 2018 | Allen Goldberg

AAM Statement on FDA’s Biosimilars Action Plan

Trump & HHS Blueprint to Lower Drug Prices (RFI)

Jul 16, 2018 | Allen Goldberg

AAM Provides Comments in Response to Administration’s Blueprint on Drug Pricing

2018 AAM Access and Savings in the U.S. Report

Jul 10, 2018 | Rachel Schwartz

Generic Drug Competition Lowers Prescription Cost to $6 on Average, Study Finds

Jun 26, 2018 | Rachel Schwartz

AAM Statement in Response to Secretary Azar’s Testimony Before Senate Finance Committee

Jun 22, 2018 | Rachel Schwartz

AAM Announces Additional 2018 Associate Members

Jun 22, 2018 | Rachel Schwartz

AAM Announces New Regular Member and Board Member

Senate Judiciary Committee Markup - CREATES Act

Jun 14, 2018 | Rachel Schwartz

AAM Statement on Senate Judiciary Committee Vote on CREATES Act

IGBA Joins ICH Management Committee

Jun 7, 2018 | Rachel Schwartz

IGBA Joins ICH Management Committee and Welcomes the Positive Vote of the General Assembly

May 31, 2018 | Rachel Schwartz

AAM Statement on FDA REMS Guidance

May 22, 2018 | Rachel Schwartz

AAM Receives Platinum and Gold Recognition from Hermes Creative Awards